Squarepoint’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-147,659
Closed -$325K 5103
2025
Q4
$325K Buy
+147,659
New +$238K ﹤0.01% 3540
2024
Q2
Sell
-61,708
Closed -$457K 4745
2024
Q1
$457K Buy
+61,708
New +$520K ﹤0.01% 3110

Other funds holding GUTS

Squarepoint's GUTS Position: Q1 2026 in Review

Squarepoint sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 147,659 shares — an estimated $325K sold.

Squarepoint first reported a position in GUTS in Q1 2024 and held it in 2 quarters. The position peaked at $457K in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Squarepoint reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 147,659 Fractyl Health shares in Q1 2026, an estimated $325K.
  • Squarepoint first reported a position in Fractyl Health in Q1 2024 and held it in 2 quarters.
  • Squarepoint's Fractyl Health position peaked at $457K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.